Answers are grounded in this paper and cite their sources.
Evaluates long-term patient adherence to telemetric IOP monitoring in glaucoma, highlighting significant acceptance and quality of life stability.
Précis: Glaucoma patients implanted with the suprachoroidal telemetric intraocular pressure sensor EyeMate-SC demonstrate sustained high acceptance and strong adherence to self-monitoring over 3 years, without compromised vision-related quality of life. Purpose: Continuous telemetric intraocular pressure (IOP) monitoring offers the potential to improve glaucoma management, yet long-term patient acceptance and adherence remain uncertain. We evaluated 3-year patient acceptability, self-monitoring adherence, and vision-related quality of life following implantation of a suprachoroidal telemetric IOP sensor. Methods: Twenty-four patients implanted with the EyeMate-SC were scheduled to complete the Telemetric Sensor Acceptance Questionnaire (TSAQ) and the NEI-VFQ-25. TSAQ responses were recorded on a 7-point Likert scale (1=complete disagreement and 7=complete agreement). Results: Twenty-one patients completed the TSAQ after 1 year (D360) and 16 after 3 years (D1080). Most would seriously consider using the sensor at home (D360: 6.6±0.6; D1080: 6.9±0.5), at work (6.1±1.1; 5.5±2.3), and while traveling (6.2±1.3; 6.4±1.0). Sensor-related problems (2.0±1.7; 1.7±1.4), subjective visual field impairment (1.6±1.4; 1.2±0.6), and foreign body sensation (1.8±1.7; 1.5±1.0) were rare. Daily routine was rarely disrupted (1.4±0.8; 1.5±1.1). Sensor use reduced anxiety about unnoticed IOP peaks in most patients (6.4±1.4; 6.5±1.1). Home monitoring variedly increased motivation to take medication (4.6±2.8; 4.3±2.6). Willingness to recommend the device was nearly unanimous (6.7±0.5; 6.6±0.6). Twenty-three patients completed the NEI-VFQ-25 at baseline, 21 at D360, and 16 at D1080. Overall, there was no significant time course (Baseline: 79.0±12.7; D360: 78.9±10.7; D1080: 77.1±10.9, p =0.7). Conclusions: The sensor was well accepted, with sustained adherence to IOP self-monitoring and stable vision-related quality of life over 3 years. This highlights the importance of patient engagement for the successful implementation of telemetric IOP self-monitoring in clinical practice.
No takes yet. Share an insight, caveat, or question.
Englisch et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: